The inclusion of comprehensive biochemical profiling, such as hormone levels (androgens, insulin and LH/FSH ratio), metabolic markers, and inflammatory mediators, would enable a more detailed exploration of how genetic polymorphisms influence metabolic and endocrine dysfunctions in PCOS. Here, PLOD1 is linked to polycystic ovary syndrome.